These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 9589225)

  • 1. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
    Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
    Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes.
    Markovic TP; Campbell LV; Balasubramanian S; Jenkins AB; Fleury AC; Simons LA; Chisholm DJ
    Diabetes Care; 1998 May; 21(5):695-700. PubMed ID: 9589226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss.
    Poynten AM; Markovic TP; Maclean EL; Furler SM; Freund J; Chisholm DJ; Campbell LV
    Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1212-8. PubMed ID: 14513069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.
    Wing RR; Blair EH; Bononi P; Marcus MD; Watanabe R; Bergman RN
    Diabetes Care; 1994 Jan; 17(1):30-6. PubMed ID: 8112186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes.
    Parker B; Noakes M; Luscombe N; Clifton P
    Diabetes Care; 2002 Mar; 25(3):425-30. PubMed ID: 11874925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus.
    Henry RR; Scheaffer L; Olefsky JM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):917-25. PubMed ID: 4044780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
    Low CC; Grossman EB; Gumbiner B
    Diabetes; 1996 May; 45(5):569-75. PubMed ID: 8621005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus.
    Henry RR; Wallace P; Olefsky JM
    Diabetes; 1986 Sep; 35(9):990-8. PubMed ID: 3527829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.
    Carey DG; Jenkins AB; Campbell LV; Freund J; Chisholm DJ
    Diabetes; 1996 May; 45(5):633-8. PubMed ID: 8621015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus.
    Kelley DE; Wing R; Buonocore C; Sturis J; Polonsky K; Fitzsimmons M
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1287-93. PubMed ID: 8077323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a behavioral weight loss program stressing calorie restriction versus calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes.
    Pascale RW; Wing RR; Butler BA; Mullen M; Bononi P
    Diabetes Care; 1995 Sep; 18(9):1241-8. PubMed ID: 8612437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.
    Heilbronn LK; Noakes M; Clifton PM
    Diabetes Care; 1999 Jun; 22(6):889-95. PubMed ID: 10372237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent v. continuous energy restriction: differential effects on postprandial glucose and lipid metabolism following matched weight loss in overweight/obese participants.
    Antoni R; Johnston KL; Collins AL; Robertson MD
    Br J Nutr; 2018 Mar; 119(5):507-516. PubMed ID: 29508693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes.
    Kelley DE; Kuller LH; McKolanis TM; Harper P; Mancino J; Kalhan S
    Diabetes Care; 2004 Jan; 27(1):33-40. PubMed ID: 14693963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss.
    Pereira MA; Swain J; Goldfine AB; Rifai N; Ludwig DS
    JAMA; 2004 Nov; 292(20):2482-90. PubMed ID: 15562127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial.
    Weiss EP; Racette SB; Villareal DT; Fontana L; Steger-May K; Schechtman KB; Klein S; Holloszy JO;
    Am J Clin Nutr; 2006 Nov; 84(5):1033-42. PubMed ID: 17093155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.
    Gougeon R; Styhler K; Morais JA; Jones PJ; Marliss EB
    Diabetes Care; 2000 Jan; 23(1):1-8. PubMed ID: 10857959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.